Serum lipids and hippocampal volume: The link to Alzheimer's disease?

Annals of Neurology

Volumn 56, Issue 5, 2004, Pages 745-749

  Wolf, Henrike ^a,b,c   Hensel, Anke ^a   Arendt, Thomas ^a   Kivipelto, Miia ^b   Winblad, Bengt ^b   Gertz, Hermann Josef ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b KAROLINSKA INSTITUTE   (Sweden)

^c AGING RESEARCH CENTER   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; CHOLESTEROL BLOOD LEVEL; COGNITION; CONTROLLED STUDY; DEMENTIA; FEMALE; HIPPOCAMPUS; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NEUROPATHOLOGY; NEUROPROTECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

EID: 9144258067     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20289     Document Type: Article

References (15)

1. Koudinov AR, Koudinova NV. Essential role for cholesterol in synaptic plasticity and neuronal degeneration. FASEB J 2001;15:1858-1860.
2. Bodovitz S, Klein WL. Cholesterol modulates α-secretase cleavage of amyloid precursor protein. J Biol Chem 1996;271:4436-4440.
3. Refolo LM, Malester B, LaFrancois J, et al. Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiol Dis 2000;7:321-331.
4. Pagan AM, Younkin LH, Morris JC, et al. Differences in the Abeta40/Abeta42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype. Ann Neurol 2000;48:201-210.
5. van Exel E, de Craen AJ, Gussekloo J, et al. Association between high-density lipoprotein and cognitive impairment in the oldest old. Ann Neurol 2002;51:716-721.
6. Kivipelto M, Helkala EL, Laakso MP, et al. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ 2001;322:1447-1451.
7. Arendt T. Synaptic plasticity and cell cycle activation in neurons are alternative effector pathways: the "Dr. Jekyll and Mr. Hyde concept" of Alzheimer's disease or the yin and yang of neuroplasticity. Prog Neurobiol 2003;71:83-248.
8. Wolf H, Hensel A, Kruggel F, et al. Structural correlates of mild cognitive impairment. Neurobiol Aging 2004;25:913-924.
9. Gosche KM, Mortimer JA, Smith CD, et al. Hippocampal volume as an index of Alzheimer neuropathology-findings from the Nun Study. Neurology 2002;58:1476-1482.
10. Bonarek M, Barberger-Gateau P, Letenneur L, et al. Relationships between cholesterol, apolipoprotein E polymorphism and dementia: a cross-sectional analysis from the PAQUID study. Neuroepidemiology 2000;19:141-148.
11. Merched A, Xia Y, Visvikis S, et al. Decreased high-density lipoprotein cholesterol and serum apolipoprotein AI concentrations are highly correlated with the severity of Alzheimer's disease. Neurobiol Aging 2000;21:27-30.
12. Mauch DH, Nagler K, Schumacher S, et al. CNS synaptogenesis promoted by glia-derived cholesterol. Science 2001;294:1354-1357.
13. Koudinov AR, Berezov TT, Kumar A, et al. Alzheimer's amyloid β interaction with normal human plasma high density lipoprotein: association with apolipoprotein and lipids. Clin Chim Acta 1998;270:75-84.
14. Cockerill GW, Huehns TY, Weerasinghe A, et al. Elevation of plasma high-density lipoprotein concentration reduces interleukin-1-induced expression of E-selectin in an in vivo model of acute inflammation. Circulation 2001;103:108-112.
15. Paterno P, Ruocco A, Postiglione A, et al. Reconstituted high-density lipoprotein exhibits neuroprotection in two rat models of stroke. Cerebrovasc Dis 2004;17:204-211.